Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](GW Pharmaceuticals Ltd.)"
Count: 50
Selected: 0
NCT IDTitle
NCT01424566A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
NCT01361607Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
NCT01337089Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
NCT01262651Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
NCT04984278Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
NCT04657666Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis
NCT04592159Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
NCT04203498Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis
NCT02432612A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer
NCT02325024A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
NCT02325011An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.
NCT02240160A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects
NCT02073474An Observational Post-Marketing Safety Registry of Sativex®
NCT01975688A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
NCT01964547A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
NCT01887301Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
NCT01610713An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT01610700An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
NCT01610687A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT01606202A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
NCT01606189A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain
NCT01606176A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
NCT01606137A Study of the Long-term Safety of Sativex Use
NCT01604265A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
NCT01599234A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
NCT01323569Abuse Potential of Sativex
NCT01323465Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex
NCT01322464Study to Assess Food Effect on Sativex Bioavailability
NCT01322139Sativex Thorough QT/QTc Study
NCT00713817A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain
NCT00713323A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.
NCT00711880A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
NCT00711646A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
NCT00710554A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
NCT00710424A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
NCT00702468Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
NCT00681538A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
NCT00678795A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
NCT00675948Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
NCT00674609A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
NCT00530764A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
NCT00391079Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
NCT02660255Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
NCT02283281Anesthetic Premedication With a Cannabis Extract (Cannapremed)
NCT01502046Neuroprotection by Cannabinoids in Huntington's Disease
NCT04447846Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
NCT02332655Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
NCT03848481CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
NCT03202303Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
NCT04423341Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm